Lucid Cap Mkts Analyst Recommendations & Stock PicksView the latest stock recommendations issued by analysts at Lucid Cap Mkts. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Lucid Cap Mkts' equity research team. MarketBeat is not affiliated with or endorsed by Lucid Cap Mkts.Updated 5/4/2026 Brokerage RankingSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROITotal Ratings20 Last 12 MonthsBuy Ratings12 Last 12 MonthsSell Ratings1 Last 12 MonthsCompanies Covered20 Last 12 Months Country All Countries USA (NYSE & NASDAQ)USA (All Exchanges)CanadaUnited Kingdom Sector All Sectors AerospaceAuto/Tires/TrucksBasic MaterialsBusiness ServicesCommunication ServicesComputer and TechnologyConstructionConsumer CyclicalConsumer DefensiveConsumer DiscretionaryConsumer GoodsConsumer StaplesEnergyFinanceFinancial ServicesIndustrialsManufacturingMedicalMiscellaneousMulti-Sector ConglomeratesReal EstateRetail/WholesaleServicesTransportationUtilities Market Cap All MarketCaps Mega Cap (More Than $200B)Large Cap ($10B-$200B)Mid Cap ($2B-$10B)Small Cap ($300M-$2B)Micro Cap ($50M-$300M)Nano Cap (Under $50M) MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Reporting Date Full History Latest Per Company Show All Ratings Strong Buy Buy Hold Sell Rating All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Price Target Change Action Any Change Raised 5%+ Raised 10%+ Raised 20%+ Lowered 5%+ Lowered 10%+ Lowered 20%+ Price Target Change Export CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetailsMDVModiv Industrial$17.88+0.6%5/4/2026 DowngradeStrong-Buy ➝ Hold00.00%View details for Lucid Cap Mkts rating of Modiv Industrial (NYSE:MDV) on 5/4/2026BBDCBarings Bdc$8.63+0.2%4/28/2026 UpgradeHold00.00%View details for Lucid Cap Mkts rating of Barings Bdc (NYSE:BBDC) on 4/28/2026XOMAXOMA Royalty$41.85+0.1%4/27/2026 DowngradeStrong-Buy ➝ Hold00.00%View details for Lucid Cap Mkts rating of XOMA Royalty (NASDAQ:XOMA) on 4/27/2026PASGPassage Bio$5.27-4.5%4/20/2026 DowngradeStrong-Buy ➝ Hold00.00%View details for Lucid Cap Mkts rating of Passage Bio (NASDAQ:PASG) on 4/20/2026MSIFMSC Income Fund$12.29+0.7%3/12/2026 UpgradeHold00.00%View details for Lucid Cap Mkts rating of MSC Income Fund (NYSE:MSIF) on 3/12/2026INMBINmune Bio$1.69+15.4%3/11/2026 UpgradeHold ➝ Strong-Buy00.00%View details for Lucid Cap Mkts rating of INmune Bio (NASDAQ:INMB) on 3/11/2026RLMDRelmada Therapeutics$7.40-1.2%3/2/2026 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of Relmada Therapeutics (NASDAQ:RLMD) on 3/2/2026VELOVelo3D$20.08-4.4%2/11/2026 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of Velo3D (NASDAQ:VELO) on 2/11/2026TVRDTvardi Therapeutics$4.00+1.1%2/4/2026 UpgradeHold ➝ Strong-Buy00.00%View details for Lucid Cap Mkts rating of Tvardi Therapeutics (NASDAQ:TVRD) on 2/4/2026QNCXQuince Therapeutics$1.21-1.2%1/30/2026 DowngradeStrong-Buy ➝ Strong Sell00.00%View details for Lucid Cap Mkts rating of Quince Therapeutics (NASDAQ:QNCX) on 1/30/2026UCUUcore Rare MetalsC$5.43-0.4%1/27/2026 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of Ucore Rare Metals (CVE:UCU) on 1/27/2026FLYXflyExclusive$2.33-1.0%1/26/2026 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of flyExclusive (NYSE:FLYX) on 1/26/2026GBDCGolub Capital BDC$13.16+0.5%1/15/2026 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of Golub Capital BDC (NASDAQ:GBDC) on 1/15/2026MNOVMediciNova$1.41+2.6%1/5/2026 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of MediciNova (NASDAQ:MNOV) on 1/5/2026SSSSSURO Capital$13.46+0.5%1/5/2026 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of SURO Capital (NASDAQ:SSSS) on 1/5/2026AIRJAirJoule Technologies$3.85+0.4%12/22/2025 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of AirJoule Technologies (NASDAQ:AIRJ) on 12/22/2025AAPGAscentage Pharma Group International$20.17-5.7%12/15/2025 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of Ascentage Pharma Group International (NASDAQ:AAPG) on 12/15/2025GSBDGoldman Sachs BDC$8.98+0.6%12/15/2025 UpgradeHold00.00%View details for Lucid Cap Mkts rating of Goldman Sachs BDC (NYSE:GSBD) on 12/15/2025HTGCHercules Capital$15.62-1.5%12/15/2025 UpgradeStrong-Buy00.00%View details for Lucid Cap Mkts rating of Hercules Capital (NYSE:HTGC) on 12/15/2025OCSLOaktree Specialty Lending$12.06+0.5%12/15/2025 UpgradeHold00.00%View details for Lucid Cap Mkts rating of Oaktree Specialty Lending (NASDAQ:OCSL) on 12/15/2025 MarketBeat Community Rating for Lucid Cap MktsMarketBeat's community ratings are surveys of what our community members think about Lucid Cap Mkts and other research firms in the last 90 days. Vote "Outperform" if you believe Lucid Cap Mkts's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Lucid Cap Mkts's recommendations will underperform the broader market over the long term. You may vote once every thirty days. Log in to vote on this brokerage. COMMUNITY RATINGS2.6out of 5 (last 90 days)2.6 of 5 stars OUTPERFORM VOTES 36 Believe will outperform the market UNDERPERFORM VOTES 33 Believe will underperform the market Lucid Cap Mkts Stock Coverage by SectorLucid Cap Mkts concentrates its research most heavily in Medical (40.0%), Finance (35.0%) and Financial Services (5.0%). The chart below shows how Lucid Cap Mkts' 20 rated companies are distributed across all 5 sectors it covers.Medical8 companies40.0%Finance7 companies35.0%Financial Services1 company5.0%Transportation1 company5.0%Business Services1 company5.0% Lucid Cap Mkts - Frequently Asked Questions What stocks does Lucid Cap Mkts currently recommend buying? Lucid Cap Mkts' analysts currently have buy-equivalent ratings on 12 companies. Recent upgrades to buy include INmune Bio and Relmada Therapeutics. What sectors does Lucid Cap Mkts specialize in? Lucid Cap Mkts has the deepest coverage in Medical (40.0% of rated companies), Finance (35.0% of rated companies), Transportation (5.0% of rated companies), Financial Services (5.0% of rated companies) and Business Services (5.0% of rated companies). How often does Lucid Cap Mkts change its stock ratings? Lucid Cap Mkts issued 20 ratings over the last 12 months across 20 companies — an average of roughly 2 rating actions per month. These include downgrade and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Lucid Cap Mkts analyst actions. Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageRoyal Bank Of CanadaJPMorgan Chase & Co.Berenberg BankWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyJefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
